regeneron 23andme - Search News

News

Regeneron To Buy 23andMe For $256M

Houston Chronicle on MSN · 8h

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase Monday.

ABC News on MSN · 1d

Regeneron Pharmaceuticals to buy 23andMe for $256M

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March following a series of setbacks.

Ars Technica · 1d

Biotech company Regeneron to buy bankrupt 23andMe for $256M

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy protection promises.

23h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, ...

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Daily Voice on MSN7h

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Regeneron makes another deal — This one about AI

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

23andMe and its user data will soon belong to a pharmaceutical giant

23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results